ARCHIVES

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010

DOD funds $4.2 million gynecologic oncology research program at four institutions.

July 2, 2004

DeVita Distressed Over “Misinformation” Circulation On Organ Systems Program

April 8, 1983

Bross Claims New Figures Show High Radiation Risk

February 23, 1979

University of Wisconsin wins $7 million NIH construction grant for cancer center.

June 25, 2004

Avon, four companies Fund NABCO Patient Information Services

January 28, 1994